Association between hand-foot skin reaction (HFSR) and survival benefit of fruquintinib in FRESCO trial.
Jin Li(Shanghai East Hospital), Wei Wang(Wellcome Sanger Institute), Shukui Qin(81th Hospital of PLA), Hongming Pan(Sir Run Run Shaw Hospital), Wei Gong, Songhua Fan, Lin Shen(Peking University), Yongqian Shu(Jiangsu Province Hospital), Yuxian Bai(Harbin Medical University), Ning Wang(Shanghai Ninth People's Hospital), Haijun Zhong(Zhejiang Cancer Hospital), Zhendong Chen(Anhui Medical University), Weijian Guo, Chao Zhu(Lilly (China)), Rui‐Hua Xu(Sun Yat-sen University), Lei Yang(Nantong Tumor Hospital), Yanhong Deng(Sun Yat-sen University), Jianming Xu(81th Hospital of PLA), Ying Yuan(Zhejiang Cancer Hospital)
Cited by 6
Related Papers
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k